• news.cision.com/
  • SpectrumOne/
  • Ampilio, a subsidiary of SpectrumOne, signs with Danish company CS MEDICA A/S to execute on expansion

Ampilio, a subsidiary of SpectrumOne, signs with Danish company CS MEDICA A/S to execute on expansion

Report this content

Ampilio, a subsidiary of SpectrumOne, partners up with stock exchange listed medical company CS MEDICA as digital business strategist, growth specialists and executor of their  global expansion on Amazon. Ampilio will run all sales, digital strategy, and expansion on Amazon with a global launch. The deal is valued at 270 000 SEK annually with a continued agreement until either partner decides otherwise. 

CS MEDICA is a Danish leading OTC Medical Device Provider active in medical technology. The company specializes in the development of medical devices. The portfolio includes products that contain medical cannabis (CBD), with the greatest focus on dietary supplements and various treatment care. August 2021, CS MEDICA announced that the Company has been approved for listing at Spotlight Stock Market.

Already involved in a strategic alliance or weighing up future options, skills are needed to build better partnerships to support the overall business strategy. Strategic Partnerships will help to create an ecosystem of strategic alliances to maximize the competitive advantage. Ampilio offers just this to CS MEDICA as a strategic partner and growth agency. Ampilio aims to understand every client’s business and in particular how to get new customers and then achieve results together with the clients in the most efficient way. For Ampilio, the journey and the end result are equally important.

Ampilio and CS MEDICA is already in talks about new business opportunities in the coming months which will be released to the public as soon as they are concluded.

Gitte Henriksen, CFO of CS MEDICA”

The strategy to build strong customer relationships drive sales, sustainability, and growth, this is something we see that the SpectrumOne group has delivered for their clients’ time and time again so our choice to work with them couldn’t have been easier, we have one of the best revolutionary CBD medical products on the market and with Ampilios help they will deliver this message to the world market and create lifelong relationships with our customers.

Hosni Teque-Omeirat, CEO SpectrumOne

Us attracting, and given the opportunity to work with, agile and dedicated companies with strong and result-oriented managements seeing the importance of a partner that is data-driven and leaning on digital and automation rather than man-hours, is truly fulfilling and a great part of our job. Having read through CS MEDICAL’S financial goals I am intensely aware of the vigorous year that is awaiting them regarding sales and activities and getting the opportunity to support and being part of that journey is strongly encouraging.

For further information contact:
Hosni Teque-Omeirat, CEO
+46 70 225 18 77

Certified Adviser:
Aktieinvest FK AB (556072-2596)
Box 7415 103 91 Stockholm
Telefon: +46 8 506 517 03

About SpectrumOne AB

SpectrumOne is a leading technology company delivering an advanced Data Management, Analytics & Communications platform suite. Offered in a SaaS online service shipping with rich market data from various professional providers, SpectrumOne provides a unique solution to many leading actors across industry segments in various countries. Enabling clients with fast and easy access to data insight and visualization coupled with powerful search, segmentation, and mapping features. SpectrumOne allows data to be quickly enabled and operationalized, driving activities from customer communication to data science supporting business analysis, strategy, and growth. All of which can be enabled the same day with immediate results. SpectrumOne´s headquarter is based in Stockholm, Sweden, responsible for Nordic sales and strategy, with additional sales and business development located in Norway, Finland, Belgium and Spain.  SpectrumOne is listed on Nasdaq First North Growth Market in Stockholm.